Delivery Order SPE2DB20D2014-SPE2DB24FB11V
- Not listed
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,097.08 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has a completion date of March 1, 2024. AmerisourceBergen Drug Corp is the prime contractor on this contract, which does not have a set-aside designation. The contract is associated with a larger indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products. The award, valued at $6,582.48, has a performance period through March 12, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical with a potential value of $999,999,999.00 and a performance period through...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, with a potential value of $1,344.53 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $3,645.51 and a period of performance through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the publicly traded Amerisourcebergen Corporation, to provide a specialty pharmaceutical product called WEGOVY 1 MG/0.5 ML PEN 0.5ML. The order, valued at $3,291.24, has a completion date of February 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- The Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML. This $19,284.13 firm fixed price contract has a completion date of September 10, 2024. AmerisourceBergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, to provide a comprehensive range of medical commodities to support military treatment...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $11,772.96 and a period of performance through April 9, 2024. This award is a task order under AmerisourceBergen's existing $999,999,999.00 indefinite delivery contract with DLA, which serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $3,324.85 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML medication. The contract has a period of performance through May 14, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $2,194.16 and a period of performance through April 9, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA with a potential value of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,021.25 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This delivery order is issued under an existing indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB11VDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $1,097.08 contract has a completion date of February 21, 2024. AmerisourceBergen Drug Corp has previously received numerous DLA contracts to provide pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities. This award is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 2/20/24 |